Heart, Vascular & Thoracic Institute (Miller Family) Outcomes
Heart Failure and Transplant
Ventricular Assist Device Implantation
Ventricular Assist Device Implantation: Volume
2015 – 2020
Since 1979, Cleveland Clinic has been using ventricular assist devices to treat patients with advanced heart failure. These devices are used in both patients who are waiting for a heart transplant (bridge-to-transplant) and in patients who are not transplant candidates (destination therapy). Cleveland Clinic uses the latest available technology to deliver excellent outcomes.
LVAD = left ventricular assist device
Continuous Flow Left Ventricular Assist Device: Postimplant Survival
June 2006 – December 2020
The Society of Thoracic Surgeons (STS) Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) is a national registry for patients with mechanical circulatory support devices. Compared to national averages, the survival rates for Cleveland Clinic LVAD (left ventricular assist device) patients are better than expected at 1 year, 3 years, and 4 years after implant.
INTERMACS = Interagency Registry for Mechanically Assisted Circulatory Support